| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16714-775-01 | 16714-775 | HUMAN PRESCRIPTION DRUG | Felbamate | Felbamate | SUSPENSION | ORAL | 20180410 | N/A | ANDA | ANDA206314 | NORTHSTAR RX LLC | FELBAMATE | 600 mg/5mL | 237 mL in 1 BOTTLE (16714-775-01) |
| 16714-775-02 | 16714-775 | HUMAN PRESCRIPTION DRUG | Felbamate | Felbamate | SUSPENSION | ORAL | 20180410 | N/A | ANDA | ANDA206314 | NORTHSTAR RX LLC | FELBAMATE | 600 mg/5mL | 473 mL in 1 BOTTLE (16714-775-02) |
| 51672-4172-1 | 51672-4172 | HUMAN PRESCRIPTION DRUG | Felbamate | Felbamate | SUSPENSION | ORAL | 20170616 | N/A | ANDA | ANDA206314 | Taro Pharmaceuticals U.S.A., Inc. | FELBAMATE | 600 mg/5mL | 237 mL in 1 BOTTLE (51672-4172-1) |
| 51672-4172-9 | 51672-4172 | HUMAN PRESCRIPTION DRUG | Felbamate | Felbamate | SUSPENSION | ORAL | 20170616 | N/A | ANDA | ANDA206314 | Taro Pharmaceuticals U.S.A., Inc. | FELBAMATE | 600 mg/5mL | 473 mL in 1 BOTTLE (51672-4172-9) |